Merck Co Stock Fundamentals
| 6MK Stock | EUR 97.00 1.60 1.62% |
Merck Co fundamentals help investors to digest information that contributes to Merck's financial success or failures. It also enables traders to predict the movement of Merck Stock. The fundamental analysis module provides a way to measure Merck's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Merck stock.
Merck |
Merck Co Company Current Valuation Analysis
Merck's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Merck Current Valuation | 286.52 B |
Most of Merck's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Merck Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Merck Co has a Current Valuation of 286.52 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The current valuation for all Germany stocks is significantly lower than that of the firm.
Merck Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Merck's current stock value. Our valuation model uses many indicators to compare Merck value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Merck competition to find correlations between indicators driving Merck's intrinsic value. More Info.Merck Co is rated fourth in return on equity category among its peers. It is rated third in return on asset category among its peers reporting about 0.35 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Merck Co is roughly 2.88 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Merck's earnings, one of the primary drivers of an investment's value.Merck Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Merck's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Merck could also be used in its relative valuation, which is a method of valuing Merck by comparing valuation metrics of similar companies.Merck is rated second in current valuation category among its peers.
Merck Fundamentals
| Return On Equity | 0.34 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.24 % | |||
| Operating Margin | 0.35 % | |||
| Current Valuation | 286.52 B | |||
| Shares Outstanding | 2.54 B | |||
| Shares Owned By Insiders | 0.09 % | |||
| Shares Owned By Institutions | 77.66 % | |||
| Price To Earning | 31.84 X | |||
| Price To Book | 6.30 X | |||
| Price To Sales | 4.45 X | |||
| Revenue | 59.28 B | |||
| Gross Profit | 42.08 B | |||
| EBITDA | 21.32 B | |||
| Net Income | 14.52 B | |||
| Cash And Equivalents | 7 B | |||
| Cash Per Share | 2.76 X | |||
| Total Debt | 28.75 B | |||
| Debt To Equity | 1.16 % | |||
| Current Ratio | 1.31 X | |||
| Book Value Per Share | 18.12 X | |||
| Cash Flow From Operations | 19.09 B | |||
| Earnings Per Share | 5.39 X | |||
| Price To Earnings To Growth | 1.35 X | |||
| Number Of Employees | 67 K | |||
| Beta | 0.37 | |||
| Market Capitalization | 254.37 B | |||
| Total Asset | 109.16 B | |||
| Z Score | 4.8 | |||
| Annual Yield | 0.03 % | |||
| Five Year Return | 2.86 % | |||
| Net Asset | 109.16 B | |||
| Last Dividend Paid | 2.76 |
About Merck Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Merck Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Merck using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Merck Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Merck Co., Inc. operates as a healthcare company worldwide. Merck Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey. MERCK DL operates under Drug ManufacturersGeneral classification in Germany and is traded on Frankfurt Stock Exchange. It employs 73000 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Merck Stock
Merck financial ratios help investors to determine whether Merck Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Merck with respect to the benefits of owning Merck security.